- Home
- REPL vs XMTR Comparison
REPL vs XMTR Comparison
Compare REPL & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- XMTR
- Stock Information
- Founded
- REPL 2015
- XMTR 2013
- Country
- REPL United States
- XMTR United States
- Employees
- REPL N/A
- XMTR N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- XMTR Industrial Machinery/Components
- Sector
- REPL Health Care
- XMTR Technology
- Exchange
- REPL Nasdaq
- XMTR Nasdaq
- Market Cap
- REPL 757.8M
- XMTR 1.1B
- IPO Year
- REPL 2018
- XMTR 2021
- Fundamental
- Price
- REPL $9.35
- XMTR $33.54
- Analyst Decision
- REPL Strong Buy
- XMTR Buy
- Analyst Count
- REPL 7
- XMTR 11
- Target Price
- REPL $20.83
- XMTR $34.82
- AVG Volume (30 Days)
- REPL 1.1M
- XMTR 740.2K
- Earning Date
- REPL 08-07-2025
- XMTR 08-07-2025
- Dividend Yield
- REPL N/A
- XMTR N/A
- EPS Growth
- REPL N/A
- XMTR N/A
- EPS
- REPL N/A
- XMTR N/A
- Revenue
- REPL N/A
- XMTR $573,810,000.00
- Revenue This Year
- REPL N/A
- XMTR $21.52
- Revenue Next Year
- REPL N/A
- XMTR $17.20
- P/E Ratio
- REPL N/A
- XMTR N/A
- Revenue Growth
- REPL N/A
- XMTR 19.35
- 52 Week Low
- REPL $6.44
- XMTR $11.08
- 52 Week High
- REPL $17.00
- XMTR $45.33
- Technical
- Relative Strength Index (RSI)
- REPL 49.55
- XMTR 53.97
- Support Level
- REPL $8.92
- XMTR $31.31
- Resistance Level
- REPL $9.93
- XMTR $33.86
- Average True Range (ATR)
- REPL 0.52
- XMTR 1.77
- MACD
- REPL -0.08
- XMTR -0.20
- Stochastic Oscillator
- REPL 22.40
- XMTR 46.80
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.